Company Filing History:
Years Active: 2014-2020
Title: Chad Schroeder: Innovator in Quinazolinone Inhibitors
Introduction
Chad Schroeder is a notable inventor based in Lawrence, Kansas, with a focus on developing innovative compounds for medical applications. He holds a total of seven patents, showcasing his contributions to the field of pharmaceutical chemistry.
Latest Patents
Among his latest patents are the 6-substituted quinazolinone inhibitors. This technology relates to compounds and compositions of Formulas I-III, which are designed for use in the treatment or prophylaxis of diseases associated with alphaviruses, such as the Venezuelan equine encephalitis virus (VEEV). The significance of these compounds lies in their potential to address serious viral infections.
Career Highlights
Chad has had a distinguished career, working with reputable institutions such as the University of Kansas. His research and development efforts have contributed significantly to advancements in medical treatments, particularly in the realm of viral diseases.
Collaborations
Throughout his career, Chad has collaborated with esteemed colleagues, including Jennifer Elizabeth Golden and Jeffrey Aube. These partnerships have enhanced his research capabilities and have led to the successful development of his patented technologies.
Conclusion
Chad Schroeder's work in the field of quinazolinone inhibitors exemplifies the impact of innovative research on public health. His contributions through patents and collaborations continue to pave the way for advancements in
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.